[HTML][HTML] Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
YY Qiu, J Zhang, FY Zeng, YZ Zhu - Pharmacological Research, 2023 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of disease phenotypes
which start with simple steatosis and lipid accumulation in the hepatocytes-a typical …
which start with simple steatosis and lipid accumulation in the hepatocytes-a typical …
[HTML][HTML] Plants-based medicine implication in the evolution of chronic liver diseases
Hepatic disorders are considered major health problems, due to their high incidence,
increased risk of chronicling or death and the costs involved in therapies. A large number of …
increased risk of chronicling or death and the costs involved in therapies. A large number of …
Effects of the 5: 2 intermittent fasting diet on non-alcoholic fatty liver disease: a randomized controlled trial
H Kord Varkaneh, A Salehi sahlabadi… - Frontiers in …, 2022 - frontiersin.org
Background and aims Dietary regimens are crucial in the management of non-alcoholic fatty
liver disease (NAFLD). The effects of intermittent fasting (IF) have gained attention in this …
liver disease (NAFLD). The effects of intermittent fasting (IF) have gained attention in this …
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk
K Yang, M Song - Nutrients, 2023 - mdpi.com
Metabolism-associated fatty liver disease (MAFLD) is a multifaceted disease that involves
complex interactions between various organs, including the gut and heart. It is defined by …
complex interactions between various organs, including the gut and heart. It is defined by …
[HTML][HTML] Национальный Консенсус для врачей по ведению взрослых пациентов с неалкогольной жировой болезнью печени и ее основными коморбидными …
МВ Маевская, ЮВ Котовская, ВТ Ивашкин… - Терапевтический …, 2022 - cyberleninka.ru
Национальный мультидисциплинарный Консенсус подготовлен при участии
Национальной медицинской Ассоциации по изучению сочетанных заболеваний …
Национальной медицинской Ассоциации по изучению сочетанных заболеваний …
[HTML][HTML] Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists …
VT Ivashkin, MV Maevskaya, MS Zharkova… - Russian Journal of …, 2022 - gastro-j.ru
Aim: present clinical guidelines, aimed at general practitioners, gastroenterologists,
cardiologists, endocrinologists, comprise up-to-date methods of diagnosis and treatment of …
cardiologists, endocrinologists, comprise up-to-date methods of diagnosis and treatment of …
Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: A pilot double-blind, placebo …
F Naeini, Z Namkhah, H Tutunchi… - European Journal of …, 2022 - journals.lww.com
Objective Although several experimental models have suggested promising
pharmacological effects of naringenin in the management of obesity and its related …
pharmacological effects of naringenin in the management of obesity and its related …
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
M Maevskaya, Y Kotovskaya, V Ivashkin… - Terapevticheskii …, 2022 - ter-arkhiv.ru
Abstract The National Consensus was prepared with the participation of the National
Medical Association for the Study of the Multimorbidity, Russian Scientific Liver Society …
Medical Association for the Study of the Multimorbidity, Russian Scientific Liver Society …
Клинические рекомендации Российского общества по изучению печени, Российской гастроэнтерологической ассоциации, Российской ассоциации …
ВТ Ивашкин, МВ Маевская, МС Жаркова… - Российский журнал …, 2022 - gastro-j.ru
Аннотация Цель: в клинических рекомендациях, предназначенных для врачей общей
практики, врачей-терапевтов, врачей-гастроэнтерологов, врачей-кардиологов, врачей …
практики, врачей-терапевтов, врачей-гастроэнтерологов, врачей-кардиологов, врачей …
[HTML][HTML] Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease
DV Garbuzenko - Gastroenterology and Hepatology from Bed to …, 2022 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease is one of the main liver diseases worldwide. The most
common cause of death in patients with nonalcoholic fatty liver disease is cardiovascular …
common cause of death in patients with nonalcoholic fatty liver disease is cardiovascular …